Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of PfizerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record. See the Pfizer group view.
As of Nov 14, 2026, FDA's public records list Seattle Genetics with 2 drug applications.
Drug applications: 2
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
Payments to Doctors (Open Payments)
What this company reported paying US doctors and teaching hospitals each year; see every company
2025: $4.7MGeneral $0.4M · Research $4.3M
2024: $0.1MGeneral $0.1M · Research $0.0M
2023: $170MGeneral $6.6M · Research $164M
2022: $145MGeneral $6.7M · Research $139M
2021: $117MGeneral $4.9M · Research $112M
2020: $77.8MGeneral $2.3M · Research $75.5M
2019: $47.6MGeneral $2.4M · Research $45.2M
Orphan Designations (FDA)
15 designations since 1983, 2 approved for the designated use, matched by the sponsor's name; see all orphan designations
brentuximab vedotinTreatment of extranodal NK/T-cell lymphoma (ENKTL) · Nov 13, 2018
TukysaTreatment of breast cancer patients with brain metastases. · Jun 5, 2017 · approved Oct 7, 2026
tucatinibTreatment of breast cancer patients with brain metastases. · Jun 5, 2017 · approved Apr 17, 2020
brentuximab vedotinTreatment of enteropathy-associated T-cell lymphoma. · Jul 7, 2016
brentuximab vedotinTreatment of adult T-cell leukemia/lymphoma · May 23, 2016
brentuximab vedotinTreatment of patients with diffuse large B-cell lymphoma. · Jan 31, 2014
brentuximab vedotinTreatment of patients with angioimmunoblastic T-cell lymphoma · Sep 13, 2013
Names and Identifiers
Appears as
SEATTLE GENETICS
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
